STAT3 signaling in ovarian cancer: a potential therapeutic target (VSports在线直播)
- PMID: 31949487
- PMCID: PMC6959025
- DOI: 10.7150/jca.35011
STAT3 signaling in ovarian cancer: a potential therapeutic target
VSports - Abstract
Accumulating evidence has shown that Signal Transducer and Activator of Transcription 3 (STAT3) is thought to be a promising target for cancer therapy as STAT3 is frequently overexpressed in a wide range of cancer cells as well as clinical specimens, promoting tumor progression VSports手机版. It is widely accepted that STAT3 regulates a variety of cellular processes, such as tumor cell growth, survival, invasion, cancer stem cell-like characteristic, angiogenesis and drug-resistance. In this review, we focus on the role of STAT3 in tumorigenesis in ovarian cancer and discuss the existing inhibitors of STAT3 signaling that can be promisingly developed as the strategies for ovarian cancer therapy. .
Keywords: STAT3; inhibitors; ovarian cancer; tumorigenesis V体育安卓版. .
© The author(s).
"VSports注册入口" Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
"VSports注册入口" Figures
References
-
- Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol. 2001;13:211–7. - PubMed
-
- Darnell JJ. STATs and gene regulation. Science. 1997;277:1630–5. - VSports注册入口 - PubMed
-
- Yu H, Jove R. The STATs of cancer-new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105. - PubMed
-
- Fan QW, Cheng CK, Gustafson WC, Charron E, Zipper P, Wong RA, Chen J, Lau J, Knobbe-Thomsen C, Weller M, Jura N, Reifenberger G. et al. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell. 2013;24:438–49. - "VSports最新版本" PMC - PubMed
Publication types
- Actions (VSports注册入口)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
